Provided by Tiger Trade Technology Pte. Ltd.

CMS

11.130
+0.3503.25%
Volume:6.20M
Turnover:68.22M
Market Cap:27.08B
PE:15.47
High:11.170
Open:10.780
Low:10.510
Close:10.780
52wk High:15.195
52wk Low:9.354
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:0.72
T/O Rate:0.25%
Dividend:0.34
Dividend Rate:3.09%
EPS(LYR):0.720
ROE:8.42%
ROA:5.62%
PB:1.29
PE(LYR):15.47
PS:2.66

Loading ...

Giant Biogene's Profit Drops on Higher Distribution Expenses

Reuters
·
Aug 18

China's Ping an Healthcare H1 Revenue Profit Jumps on Corporate Client Base Expansion

Reuters
·
Aug 18

Denmark's Coloplast Q3 Revenue up on Chronic Care, Urology Growth

Reuters
·
Aug 18

Sweden's OssDsign Q2 Sales Rise 2.4% Gross Margin Falls

Reuters
·
Aug 18

CMS Announces RMB 0.1643 Interim Dividend per Share for 1H 2026, Payable on 8 September

Bulletin Express
·
Aug 17

CMS Announces Interim Results: Net Profit Attributable to Shareholders Up 4.77% to RMB 986 Million

Stock News
·
Aug 17

China Medical System Holdings H1 Net Income Attributable RMB 986.1 Million

THOMSON REUTERS
·
Aug 17

China Medical System H1 FY26 Profit Rises 4.3% to RMB 971.5 Million; Revenue Climbs 12.5% to RMB 4.5 Billion

Reuters
·
Aug 17

CMS sets 17 Aug 2026 board meeting to approve H1 2026 results and consider interim dividend

Bulletin Express
·
Aug 05

China Medical System Schedules Board Meeting to Review Interim Results, Weigh Dividend

Reuters
·
Aug 05

CMS Reports No Share Capital Changes and Confirms Public Float Compliance for July 2026

Bulletin Express
·
Aug 03

Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth

Simply Wall St.
·
Jul 19

On Holding Stock And 2 Founder Led Picks Investors Are Watching Closely

Simply Wall St.
·
Jul 17

China Medical System Secures Clinical Trial Approval for Macular Degeneration Drug

MT Newswires
·
Jul 16

China Medical System Says Nmpa Approves Clinical Trials of Cms-d017

Reuters
·
Jul 16

CMS Receives Clinical Trial Approval for Its Novel Complement Factor B Inhibitor in Age-Related Macular Degeneration

Stock News
·
Jul 15

CMS secures NMPA clearance to begin clinical trials of oral complement factor B inhibitor CMS-D017 for age-related macular degeneration

Bulletin Express
·
Jul 15

China Medical System Wins Trial Nod for New AMD Drug CMS-D017

TIPRANKS
·
Jul 15

China Medical System Holdings - Nmpa Approves Clinical Trials of Cms-d017 for Age-related Macular Degeneration

THOMSON REUTERS
·
Jul 15

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Deep News
·
Jul 13